Lipopolysaccharide variation in Coxiella burnetti: intrastrain heterogeneity in structure and antigenicity.
about
Genetic diversity of the Q fever agent, Coxiella burnetii, assessed by microarray-based whole-genome comparisonsQ feverPhase and antigenic variation in bacteriaIdentification of OmpA, a Coxiella burnetii protein involved in host cell invasion, by multi-phenotypic high-content screeningFrom Q Fever to Coxiella burnetii Infection: a Paradigm Change.Coxiella burnetii phase I and II variants replicate with similar kinetics in degradative phagolysosome-like compartments of human macrophagesProteomic and systems biology analysis of the monocyte response to Coxiella burnetii infection.Identification and characterization of an immunodominant 28-kilodalton Coxiella burnetii outer membrane protein specific to isolates associated with acute disease.Diagnosis of Q fever.Direct identification of Coxiella burnetii plasmids in human sera by nested PCRWhole-Genome Sequence of Coxiella burnetii Nine Mile RSA439 (Phase II, Clone 4), a Laboratory Workhorse Strain.Coxiella burnetii transcriptional analysis reveals serendipity clusters of regulation in intracellular bacteria.Genomotyping of Coxiella burnetii using microarrays reveals a conserved genomotype for hard tick isolatesCoxiella burnetii induces apoptosis during early stage infection via a caspase-independent pathway in human monocytic THP-1 cellsChromosomal DNA deletions explain phenotypic characteristics of two antigenic variants, phase II and RSA 514 (crazy), of the Coxiella burnetii nine mile strain.Development of a lipopolysaccharide-targeted peptide mimic vaccine against Q feverCoxiella burnetii acid phosphatase inhibits the release of reactive oxygen intermediates in polymorphonuclear leukocytes.Q fever - a reviewImmunoreactive Coxiella burnetii Nine Mile proteins separated by 2D electrophoresis and identified by tandem mass spectrometry.Evaluation of the high-density agglutination test for Coxiella burnetii antibodies in animalsProteome and antigen profiling of Coxiella burnetii developmental formsMajor differential gene regulation in Coxiella burnetii between in vivo and in vitro cultivation modelsEfficient method of cloning the obligate intracellular bacterium Coxiella burnetiiElectrophoretic and chemical characterization of lipopolysaccharides of Vibrio parahaemolyticus.Chlamydial hemagglutinin identified as lipopolysaccharideRole of B cells in host defense against primary Coxiella burnetii infection.Robust growth of avirulent phase II Coxiella burnetii in bone marrow-derived murine macrophagesVaccine prophylaxis of abattoir-associated Q fever: eight years' experience in Australian abattoirs.Serological cross-reactions between Bartonella quintana, Bartonella henselae, and Coxiella burnetii.Lipopolysaccharide phase variation determines the complement-mediated serum susceptibility of Coxiella burnetii.Steric hindrance of antibody binding to surface proteins of Coxiella burnetti by phase I lipopolysaccharide.Changes in infectivity and plasmid profile of the Lyme disease spirochete, Borrelia burgdorferi, as a result of in vitro cultivation.Endotoxicosis induced by Coxiella burnetii lipopolysaccharide stimulates a ribosomal protein S6 kinase: some properties of the partially purified enzyme.Comparative virulence of intra- and interstrain lipopolysaccharide variants of Coxiella burnetii in the guinea pig model.The surface of virulent Treponema pallidum: resistance to antibody binding in the absence of complement and surface association of recombinant antigen 4D.Antigenic variation in the phase I lipopolysaccharide of Coxiella burnetii isolatesEnzyme-linked immunosorbent fluorescence assay and high-pressure liquid chromatography for analysis of humoral immune responses to Coxiella burnetti proteins.Isolation of 16 strains of Coxiella burnetii from patients by using a sensitive centrifugation cell culture system and establishment of the strains in HEL cells.The attenuated nine mile phase II clone 4/RSA439 strain of Coxiella burnetii is highly virulent for severe combined immunodeficient (SCID) miceInhibition of the human neutrophil NADPH oxidase by Coxiella burnetii
P2860
Q24542438-11BBE915-570C-4AE8-A62B-B5BDCF56795DQ24550722-96EDEF4E-9EF8-488C-A90C-0F4154D2D906Q24561666-402B109D-ED89-4C33-99CD-8D9A38357CE5Q28541251-84769C87-5C9B-4A98-93FE-E0D2F87C9C07Q30241105-0F16D1CA-F234-404C-A32F-AEECCD3F5EF5Q30495882-CAAB6A7D-42BD-4EEF-A841-5D3AF3150640Q31130533-425717D2-266A-40C4-9B60-71EAADA511F5Q33212293-EA6CAD52-EE8E-44D0-A5C6-17EB3BA1F207Q33671756-703A6612-4915-460F-AE80-5C82CBCEF8F3Q33675352-1CA607C0-74FB-41B8-A620-E1816D24C7D5Q33781778-1830A657-0941-4222-BDB4-294C64C5AC0DQ33784837-6B9D8A20-F7BB-4B0E-B5A7-451E2A975EB7Q34064326-D6F3DA5A-4768-4F1D-9C75-B82FECF31D0AQ34150024-AFD73099-5A83-4EB8-BFF6-176A423A8B17Q34258745-6A62DD63-7377-490D-8530-9F920E10EDC2Q34440031-410E5DCC-2DF4-4BA2-86F0-CE7D37F49135Q34484432-7FB755C6-EB76-4348-B10E-1F57771EF14EQ34578503-FA8E39E8-E19C-406B-BE0E-7C319FDA23C2Q34954517-64945CCA-768D-46CD-B5B8-9B5D149FCAF9Q35231823-75FDD816-CB3C-4ACE-B408-55CC44BBB0CFQ35689040-9AA2B443-2B2F-4E98-B9B4-456CEC9C1473Q35842594-27886DB8-1C16-4436-AF59-F73EF5D15C4AQ35913134-40F2A2F7-0798-430C-8CA4-CC42EB0E0553Q36111499-4FA735A3-779B-4A8E-85D9-E2DB2CF8AA2AQ36241169-9C185440-A674-49DD-9B61-162F47BF495BQ36281310-0CB79853-2BC0-4FBD-98AE-B3D0097960D5Q36302835-A11261CB-516A-49C7-B1B5-B82849A87ECFQ36504818-BA08DBB2-9BE8-4AA0-B6E1-921F06C33362Q36538087-CF8CF140-E05D-4D0B-9A82-D68A8DCF513AQ36992338-61DE0EA0-A219-43B2-B342-A0C22C04D5D6Q36995652-3D4578A9-0463-4C70-AE18-D04F421778F5Q36997714-46324314-89FE-4382-A0EA-75C8A1ACF48EQ37006801-3CEED032-C377-43D5-96C7-A329357B9F68Q37018394-08B3E940-3A6F-462C-99B2-5E0B075B91DBQ37029519-E2D3BC9E-EFC1-48AB-B25A-AEC63C15195FQ37054492-A92093F4-9574-4F97-ABBC-F0DA935711D9Q37159037-985B2035-4D54-47EF-A980-400010F9B91EQ37192219-30EDD756-1470-4FFF-94B9-09D29CEBD2EEQ37225839-AA8A633B-4EA9-411D-B570-7EDC856B732EQ37246574-E5C4A08F-1641-4013-BAFF-3F260FCB077D
P2860
Lipopolysaccharide variation in Coxiella burnetti: intrastrain heterogeneity in structure and antigenicity.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on May 1985
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Lipopolysaccharide variation i ...... in structure and antigenicity.
@en
Lipopolysaccharide variation i ...... in structure and antigenicity.
@nl
type
label
Lipopolysaccharide variation i ...... in structure and antigenicity.
@en
Lipopolysaccharide variation i ...... in structure and antigenicity.
@nl
prefLabel
Lipopolysaccharide variation i ...... in structure and antigenicity.
@en
Lipopolysaccharide variation i ...... in structure and antigenicity.
@nl
P2093
P2860
P1476
Lipopolysaccharide variation i ...... in structure and antigenicity.
@en
P2093
Hackstadt T
Hitchcock PJ
Peacock MG
P2860
P304
P407
P577
1985-05-01T00:00:00Z